Lisa Gray

Lists and Charts

Rank	Company	1 yr	5 yr
607^th	Artrya	4%
766^th	Advanced Health Intelligence	-2%	-24%
949^th	Zelira Therapeutics	-14%	-38%
1406^th	Strategic Elements	-46%	11%
1720^th	Roots Sustainable Agricultural Technologies	-67%	-62%

1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

03/02/22

$1.6m Other

03/02/22

$1.6m Bought

05/10/20

$0 Sold

Total value as at the date of the transaction

Rank	Company	Revenue
155^th	Zelira Therapeutics	$1.6m
170^th	Artrya	$996k
171^st	Strategic Elements	$855k
173^rd	Advanced Health Intelligence	$772k
174^th	Roots Sustainable Agricultural Technologies	$630k

201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®

Collapse All Lists and Charts

07 Jun 2023

Position	Company	Year	Company's current rank
Non-Executive Director	Zelira Therapeutics	2019 - 2023	155

Company	Date	Transaction type	Number of shares	Price per share	Transaction value	Nature of change
Zelira Therapeutics	03 Feb 2022	Other	58,641,228	$0.03	$1,641,954	OtherConversion of securities: 58,641,228 performance rights
Zelira Therapeutics	03 Feb 2022	Bought	58,641,228	$0.03	$1,641,954	OtherConversion of securities
Zelira Therapeutics	05 Oct 2020	Sold	8,206,500			Off-market trade
Zelira Therapeutics	02 Jan 2020	Issued	16,413,065	$0.06	$902,719	OtherIssue of securities
Zelira Therapeutics	02 Jan 2020	Issued	104,782,456			OtherIssue of securities: 104,782,456 - performance rights.